Alerts will be sent to your verified email
Verify Email
ADVENZYMES
|
Advanced Enzyme
|
Fermenta Biotech
|
Concord Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
10.41 % | 2.59 % | 2.3 % |
|
Financials
|
|||
|
5 yr Average ROE
|
10.77 % | 2.76 % | 19.73 % |
|
5yr average Equity Multiplier
|
1.15 | 1.95 | 1.21 |
|
5yr Average Asset Turnover Ratio
|
0.41 | 0.59 | 0.54 |
|
5yr Avg Net Profit Margin
|
22.63 % | 2.17 % | 30.4 % |
|
Price to Book
|
2.33 | 2.26 | 8.04 |
|
P/E
|
23.43 | 7.9 | 45.34 |
|
5yr Avg Cash Conversion Cycle
|
109.31 Days | -30.1 Days | 76.63 Days |
|
Inventory Days
|
77.49 Days | 127.88 Days | 79.03 Days |
|
Days Receivable
|
61.31 Days | 64.16 Days | 132.49 Days |
|
Days Payable
|
49.86 Days | 154.92 Days | 157.9 Days |
|
5yr Average Interest Coverage Ratio
|
54.21 | 2.37 | 195.92 |
|
5yr Avg ROCE
|
14.52 % | 10.4 % | 25.76 % |
|
5yr Avg Operating Profit Margin
|
35.47 % | 14.91 % | 43.43 % |
|
5 yr average Debt to Equity
|
0.02 | 0.54 | 0.03 |
|
5yr CAGR Net Profit
|
-2.12 % | 11.05 % | 9.62 % |
|
5yr Average Return on Assets
|
9.32 % | 1.67 % | 16.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.07 % | 64.09 % | 44.08 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.8 % | 4.51 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
-2.12 % | 0.0 | -1.05 % |
|
Advanced Enzyme
|
Fermenta Biotech
|
Concord Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|